Prostate Cancer 18F-PSMA-1007 PET/CT Access Trial
ConditionProstate Cancer
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
Age18+
SponsorAlberta Health services
About this trial
Primary objective:
• To determine if 18F-PSMA-1007 PET/CT imaging is effective at diagnosing prostate cancers and/or metastases compared to conventional imaging \[including CT, MRI, 99mTc-MDP Bone Scans as available\].
Secondary Objective:
* To determine safety by evaluating for adverse events * To determine which conventional imaging is being performed when 18F-PSMA-1007 PET/CT imaging is available
Eligibility criteria
Qualifiers
Age greater than or equal to 18 years.
Able and willing to follow instructions and comply with the protocol.
Provide written informed consent prior to participation in the study.
a history of radical prostatectomy for treatment of prostate cancer, and a serum prostate specific antigen (PSA) ≥ 0.2 µg/L
Disqualifiers
Unable to obtain consent
Age less than 18 years.
Unable to lie flat for 30 minutes to compete PET/CT imaging.
Lack of intravenous access
Trial design
Treatments tested in this trial
- 18F-1007 PSMA PSMA PET/CT
Treatment groups
No treatment groups listed
Locations
Sponsors and collaborators
Source ClinicalTrials.gov